Novo Nordisk expects continued competition from copycat versions of its blockbuster Wegovy obesity drug this year and could ...

The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.

Booming sales of Wegovy powered the company to become Europe's most valuable, but it has lost over $400 billion in market ...

In a pooled analysis of three randomized trials, CPAP had overall null cardiovascular effects in patients with obstructive ...

Impax Asset Management, an investment management company, released its “Impax US Sustainable Economy Fund” second quarter ...

Eli Lilly offers an annual dividend yield of 0.78%. So, how can investors exploit its dividend yield to pocket a regular $500 ...

Eli Lilly (LLY) reports Q2 earnings on Aug 7, with booming diabetes and weight-loss drug sales driving strong growth.

Eli Lilly is eligible for 100M in tax credits to expand its Pleasant Prairie facility, adding 750 jobs and boosting Wisconsin ...

Eli Lilly and Company (NYSE:LLY) is one of the stocks in Jim Cramer’s game plan for this week. Cramer highlighted that his ...

When Eli Lilly reports its financial results early Thursday, investors will be looking for the company to press its advantage ...

The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications.

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...